Robeco Institutional Asset Management B.V. increased its holdings in Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report) by 22.2% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,107,917 shares of the financial services provider’s stock after buying an additional 201,056 shares during the quarter. Robeco Institutional Asset Management B.V. owned about 0.23% of Marsh & McLennan Companies worth $189,155,000 at the end of the most recent reporting period.
Other institutional investors also recently bought and sold shares of the company. SHP Wealth Management purchased a new position in shares of Marsh & McLennan Companies during the fourth quarter worth $26,000. Asset Dedication LLC acquired a new stake in Marsh & McLennan Companies during the 1st quarter worth about $25,000. Pinnacle Bancorp Inc. acquired a new stake in Marsh & McLennan Companies during the 1st quarter worth about $28,000. Canton Hathaway LLC purchased a new position in shares of Marsh & McLennan Companies during the 1st quarter valued at about $28,000. Finally, EFG International AG purchased a new position in shares of Marsh & McLennan Companies during the 2nd quarter valued at about $30,000. 87.99% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling
In other news, insider Martin South sold 7,100 shares of the business’s stock in a transaction that occurred on Tuesday, July 28th. The stock was sold at an average price of $189.99, for a total value of $1,348,929.00. Following the completion of the sale, the insider directly owned 16,632 shares in the company, valued at $3,159,913.68. The trade was a 29.92% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Lloyd M. Yates sold 12,000 shares of the business’s stock in a transaction that occurred on Thursday, July 23rd. The shares were sold at an average price of $175.65, for a total value of $2,107,800.00. Following the completion of the sale, the director owned 12,001 shares of the company’s stock, valued at $2,107,975.65. This trade represents a 50.00% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 19,813 shares of company stock valued at $3,597,903. 0.38% of the stock is owned by company insiders.
Wall Street Analyst Weigh In
A number of analysts have recently commented on MRSH shares. Keefe, Bruyette & Woods upped their target price on Marsh & McLennan Companies from $186.00 to $201.00 and gave the stock a “market perform” rating in a research note on Monday. Mizuho raised their target price on Marsh & McLennan Companies from $190.00 to $200.00 and gave the stock a “neutral” rating in a report on Monday. Morgan Stanley reduced their price target on Marsh & McLennan Companies from $200.00 to $180.00 and set an “equal weight” rating for the company in a research report on Tuesday, October 6th. The Goldman Sachs Group decreased their price target on Marsh & McLennan Companies from $197.00 to $191.00 and set a “neutral” rating for the company in a report on Thursday, October 1st. Finally, JPMorgan Chase & Co. boosted their price target on Marsh & McLennan Companies from $215.00 to $218.00 and gave the company an “overweight” rating in a report on Tuesday. Two analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating, eleven have given a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $204.42.
Get Our Latest Report on Marsh & McLennan Companies
Marsh & McLennan Companies Stock Performance
MRSH opened at $191.40 on Wednesday. The firm has a fifty day moving average price of $181.14. The stock has a market capitalization of $91.01 billion, a PE ratio of 18.12, a price-to-earnings-growth ratio of 2.62 and a beta of 0.59. Marsh & McLennan Companies, Inc. has a fifty-two week low of $156.60 and a fifty-two week high of $198.49. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 1.27.
Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) last posted its earnings results on Thursday, October 15th. The financial services provider reported $2.03 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.96 by $0.07. Marsh & McLennan Companies had a net margin of 14.20% and a return on equity of 33.32%. The business had revenue of $6.86 billion for the quarter. Marsh & McLennan Companies’s quarterly revenue was up 8.1% on a year-over-year basis. On average, equities research analysts forecast that Marsh & McLennan Companies, Inc. will post 10.45 earnings per share for the current year.
Marsh & McLennan Companies Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Thursday, October 1st will be issued a $0.99 dividend. The ex-dividend date of this dividend is Thursday, October 1st. This represents a $3.96 dividend on an annualized basis and a yield of 2.1%. Marsh & McLennan Companies’s dividend payout ratio is presently 47.37%.
Marsh & McLennan Companies Company Profile
Marsh & McLennan Companies is a global professional services firm that provides advice and solutions in risk, strategy and people. The company serves businesses, governments and institutions through a portfolio of specialized businesses focused on insurance brokerage, reinsurance, consulting and talent management.
Its principal businesses include Marsh, an insurance brokerage and risk advisory firm; Guy Carpenter, a provider of reinsurance brokerage and related risk-management services; Mercer, which offers consulting in investment, retirement, health and workforce strategy; and Oliver Wyman, a management consulting firm serving clients across industries and regions.
Founded in 1905, Marsh & McLennan serves clients in countries and markets around the world.
Recommended Stories
- Five stocks we like better than Marsh & McLennan Companies
- Aurora Rejects Curaleaf’s Higher Bid, But the Takeover Fight Isn’t Over
- Centrus Energy Is Building a Nuclear Fuel Powerhouse—Why Is Its Stock Struggling?
- Halliburton Gains Traction: Multiyear Upcycle Ahead
- Meta Platforms’ AI Comeback Faces an Earnings Test—And a $10 Billion Charge
Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report).
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
